SA
Log In
DOC
OverviewIntelligenceChart

Analyst Sentiment

Analysts lean bullish — 53% recommend buying.

Consensus Rating
Buy
30 analysts·High coverage
53%
Rating Distribution
Strong Buy
00%
Buy
1653%
Hold
1447%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Price is near analyst consensus — limited near-term upside expected.

Bear Case
$17.00
-1%
Consensus
$18.00
+5%
Bull Case
$21.00
+22%
Price Range30 analysts
Low
Consensus
High
$17.00
$21.00
Current Target
Current Price
$17.18
Upside to Target
$0.82

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+4.72%
EPS+19.64%
FY2028
Rev+4.93%
EPS+10.15%

Earnings Surprises

Recent Analyst Actions

Feb 3, 2026Wells Fargo
Healthpeak Properties price target lowered to $18 from $19 at Wells Fargo
Target:$18.00
+6.4%from $16.92
Jan 9, 2026Goldman Sachs
Healthpeak Properties initiated with a Neutral at Goldman Sachs
Target:$17.00
-0.2%from $17.04
Jan 5, 2026Cantor Fitzgerald
Healthpeak Properties price target lowered to $17 from $20 at Cantor Fitzgerald
Target:$17.00
+5.2%from $16.16
Dec 15, 2025Jefferies
Healthpeak Properties downgraded to Hold from Buy at Jefferies
Target:$17.00
+2.0%from $16.66
Dec 15, 2025Evercore ISI
Healthpeak Properties price target lowered to $21 from $22 at Evercore ISI
Target:$21.00
+25.0%from $16.80
Oct 1, 2025Cantor Fitzgerald
Healthpeak Properties initiated with a Neutral at Cantor Fitzgerald
Target:$20.00
+4.4%from $19.15
Sep 15, 2025Evercore ISI
Healthpeak Properties price target lowered to $22 from $23 at Evercore ISI
Target:$22.00
+21.7%from $18.08
Sep 15, 2025Raymond James
Healthpeak upgraded to Outperform from Market Perform at Raymond James
Target:$20.00
+9.6%from $18.25
Aug 22, 2025Morgan Stanley
Healthpeak Properties price target lowered to $21 from $22 at Morgan Stanley
Target:$21.00
+18.3%from $17.75
Jul 30, 2025Robert W. Baird
Healthpeak Properties price target lowered to $21 from $22 at Baird
Target:$21.00
+22.0%from $17.22
Oct 21, 2024Deutsche Bank
Deutsche upgrades Healthpeak to Buy on improving life sciences sector
Target:$28.00
+23.7%from $22.64
Aug 21, 2024Citigroup
Healthpeak Properties price target raised to $22 from $20 at Citi
Target:$22.00
+0.5%from $21.89
Jul 30, 2024Robert W. Baird
Healthpeak Properties Inc (DOC) PT Raised to $24 at Baird
Target:$24.00
+9.8%from $21.85
Jul 30, 2024RBC Capital
Healthpeak Properties Inc (DOC) PT Raised to $25 at RBC Capital
Target:$25.00
+14.4%from $21.85
May 3, 2024Wedbush
Wedbush Upgrades Healthpeak Properties Inc (DOC) to Outperform
Target:$22.00
+14.8%from $19.17
Apr 10, 2024RBC Capital
Healthpeak Properties Inc (DOC) PT Raised to $22 at RBC Capital
Target:$22.00
+13.8%from $19.34
Mar 27, 2024Robert W. Baird
Healthpeak Properties Inc (DOC) PT Lowered to $22 at Baird
Target:$22.00
+20.2%from $18.31
Mar 25, 2024Wells Fargo
Wells Fargo Resumes Healthpeak Properties Inc (DOC) at Equal Weight
Target:$19.00
+8.3%from $17.54
Aug 1, 2023Credit Suisse
Check Out 3 Real Estate Stocks With Over 6% Dividend Yields From Wall Street's Most Accurate Analysts
Target:$15.00
+2.5%from $14.64
Aug 31, 2022Morgan Stanley
Morgan Stanley Maintains Equal-Weight on Physicians Realty Trust, Raises Price Target to $16.5
Target:$16.50
-2.7%from $16.95
Jul 15, 2022Morgan Stanley
Morgan Stanley Maintains Equal-Weight on Physicians Realty Trust, Lowers Price Target to $16
Target:$16.00
-4.5%from $16.76
Jul 11, 2022Truist Financial
Truist Securities Maintains Hold on Physicians Realty Trust, Lowers Price Target to $17
Target:$17.00
+2.5%from $16.58
Jun 30, 2022Jefferies
Jefferies Maintains Buy on Physicians Realty Trust, Lowers Price Target to $20
Target:$20.00
+13.8%from $17.58
Jun 1, 2022Morgan Stanley
Morgan Stanley Maintains Equal-Weight on Physicians Realty Trust, Lowers Price Target to $17.5
Target:$17.50
-5.7%from $18.55
Apr 26, 2022Barclays
Barclays Initiates Coverage On Physicians Realty Trust with Overweight Rating, Announces Price Target of $20
Target:$20.00
+13.8%from $17.58

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance